市場調査レポート

脳卒中管理の米国市場

U.S. Markets for Stroke Management

発行 Medtech Insight 商品コード 338477
出版日 ページ情報 英文 170 Pages, 44 Exhibits
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
脳卒中管理の米国市場 U.S. Markets for Stroke Management
出版日: 2015年08月28日 ページ情報: 英文 170 Pages, 44 Exhibits
概要

米国の脳卒中管理の市場は2014年から2019年にかけて5.1%のCAGRで成長すると予測されています。製品区分別で見ると、診断画像製品部門は3.6%、外科・血管関連製品の市場は5.4%のCAGRとなると予測されています。

当レポートは、米国における脳卒中管理市場の動向について調査し、脳卒中の概要、脳卒中の診断関連製品・介入的処置関連製品・薬剤の種類と概要、処置件数および市場規模の推移と予測、市場成長への影響因子の分析、米国の主要サプライヤーの市場シェア、主要サプライヤーの製品ポートフォリオ、新しい技術の分析などについてまとめています。

エグゼクティブサマリー

第1章 臨床概要

  • 虚血性脳卒中
    • 症状・リスク因子
    • 一過性虚血性発作
  • 出血性卒中
    • 症状・リスク因子
    • 脳動脈瘤
    • 動静脈奇形

第2章 脳卒中の臨床的管理

  • 脳卒中の診断・診断画像
    • CT
    • MRI
    • 診断超音波
    • 脳血管造影
    • 核医学画像
      • ガンマカメラによるイメージング
      • PET
  • 脳卒中の治療管理
    • 薬理的予防・治療モダリティ
      • 抗凝固薬
      • 降圧剤
      • 抗血小板薬
      • 血栓溶解剤
    • 外科的介入・血管介入
      • 頚動脈狭窄
      • 頭蓋内動脈瘤・動静脈奇形
  • 脳卒中の予防・管理の新しい治療法
    • 細胞治療
    • Intrasaccular Occlusion用デバイス
    • 超音波血栓溶解
    • 脳・側副血流強化システム
    • 神経保護システム
    • その他の血栓溶解剤

第3章 脳卒中管理製品

  • 診断画像システム
    • CT製品
      • 市場予測
      • 競合分析
    • MRI製品
      • 市場予測
      • 競合分析
    • 診断用超音波製品
      • 市場予測
      • 競合分析
    • 核医学画像製品
      • 市場予測
      • 競合分析
    • 脳血管造影製品
      • 市場予測
      • 競合分析
  • 薬剤治療製品
    • 経口抗凝固剤
      • 市場予測
    • 経口降圧剤
      • 市場予測
    • 経口抗血小板剤
      • 市場予測
    • 静脈内血栓溶解剤
      • 市場予測
  • 介入的脳卒中管理システム
    • 脳卒中予防のための外科的・血管内システム
      • 頸動脈内膜剥離術
      • 頸動脈ステント留置
      • 脳動脈瘤/動静脈奇形の外科的クリッピングシステム
      • 脳動脈瘤/動静脈奇形の血管塞栓システム
    • 脳卒中管理のための脳血管内システム
      • 脳塞栓摘出/機械的血栓摘出製品
      • 頭蓋内ステント留置
      • 分流技術

付録:企業リスト

文献

目次
Product Code: A226

The United States (U.S.) market for stroke management products, which encompasses diagnostic and therapeutic systems, is a market composed of old and new technologies that are often used together in order to prevent and treat stroke. Improvements in stroke diagnostic systems will facilitate the delivery of timely stroke therapies within the optimum treatment window for patients suffering from stroke. Topics covered in this report include:

  • diagnostic, interventional, and pharmaceutical stroke-related products;
  • procedure and market forecasts for the years 2014 to 2019;
  • key factors influencing the growth of individual product markets;
  • estimated market shares and sales among major U.S. suppliers;
  • major supplier product portfolio analysis in individual product markets; and,
  • emerging technology that could potentially change the way stroke is diagnosed and treated, which could potentially change how product markets develop.

Over the forecast period covered in this report (2014 through 2019), the estimated value of the U.S. market for stroke management systems (not including pharmaceutical agents) is expected to grow by approximately $284.2 million at compound annual growth rate (CAGR) of 5.1%; for the overall stroke management market; diagnostic imaging products are forecasted to grow at a CAGR of 3.6%, while surgical and endovascular products will grow at a CAGR of 5.4%.

Table of Contents

EXECUTIVE SUMMARY

  • i. Methodology

Exhibit ES-1: 2014, U.S. Stroke Management Market, Shares by Product Markets

1. CLINICAL OVERVIEW

  • 1.1 Ischemic Stroke
    • 1.1.1 Symptoms and Risk Factors
    • 1.1.2 Transient Ischemic Attack
  • 1.2 Hemorrhagic Stroke
    • 1.2.1 Symptoms and Risk Factors
    • 1.2.2 Cerebral Aneurysm
    • 1.2.3 Arteriovenous Malformations
  • Exhibit 1-1: 2015, Clinical Features and Characteristics of Ischemic Stroke
  • Exhibit 1-2: 2015, Clinical Features and Characteristics of Hemorrhagic Stroke
  • Exhibit 1-3: 2015, Cerebral Aneurysm, Facts and Figures

2. CLINICAL MANAGEMENT OF STROKE

  • 2.1 Stroke Diagnostics and Diagnostic Imaging
    • 2.1.1 Computed Tomography
      • 2.1.1.1 Stroke-Related Applications of Computed Tomography
    • 2.1.2 Magnetic Resonance Imaging
      • 2.1.2.1 Stroke-Related Applications of Magnetic Resonance Imaging
    • 2.1.3 Diagnostic Ultrasound
      • 2.1.3.1 Stroke-Related Applications of Diagnostic Ultrasound
    • 2.1.4 Cerebral Angiography
      • 2.1.4.1 Stroke-Related Applications of Cerebral Angiography
    • 2.1.5 Nuclear Medicine Imaging
      • 2.1.5.1 Gamma Camera Imaging
      • 2.1.5.2 Positron Emission Tomography
      • 2.1.5.3 Stroke-Related Applications of Nuclear Medicine Imaging
  • 2.2 Therapeutic Management of Stroke
    • 2.2.1 Pharmacologic Preventative and Therapeutic Modalities
      • 2.2.1.1 Anticoagulation Drug Therapy
      • 2.2.1.2 Antihypertensive Drug Therapy
      • 2.2.1.3 Antiplatelet Drug Therapy
      • 2.2.1.4 Thrombolytic Drug Therapy
    • 2.2.2 Surgical and Endovascular Interventions
      • 2.2.2.1 Carotid Artery Stenosis
        • 2.2.2.1.1 Carotid Endarterectomy
        • 2.2.2.1.2 Carotid Artery Stenting
      • 2.2.2.2 Intracranial Aneurysms and Arteriovenous Malformations
        • 2.2.2.2.1 Surgical Repair
        • 2.2.2.2.2 Endovascular Embolization
        • 2.2.2.2.3 Gamma Knife System
        • 2.2.2.2.4 Intracranial Stenting Systems
        • 2.2.2.2.5 Cerebral Thrombectomy Systems
        • 2.2.2.2.6 Flow Diverter Technology
  • 2.3 Emerging Therapies in Stroke Prevention and Management
    • 2.3.1 Cellular Therapy
    • 2.3.2 Intrasaccular Occlusion Devices
    • 2.3.3 Sonothrombolysis
    • 2.3.4 Cerebral Collateral Flow Enhancement Systems
    • 2.3.5 Neuroprotection Systems
    • 2.3.6 Other Thrombolytic Agents
  • Exhibit 2-1: Carotid Endarterectomy
  • Exhibit 2-2: Carotid Artery Stenting
  • Exhibit 2-3: Embolic Coiling
  • Exhibit 2-4: Endovascular Embolization

3. STROKE MANAGEMENT PRODUCTS

  • 3.1 Diagnostic Imaging Systems
    • 3.1.1 Computed Tomography Products
      • 3.1.1.1 Market Forecast
      • 3.1.1.2 Competitive Analysis
    • 3.1.2 Magnetic Resonance Imaging Products
      • 3.1.2.1 Market Forecast
      • 3.1.2.2 Competitive Analysis
    • 3.1.3 Diagnostic Ultrasound Products
      • 3.1.3.1 Market Forecast
      • 3.1.3.2 Competitive Analysis
    • 3.1.4 Nuclear Medicine Imaging Products
      • 3.1.4.1 Market Forecast
      • 3.1.4.2 Competitive Analysis
    • 3.1.5 Cerebral Angiography Products
      • 3.1.5.1 Market Forecast
      • 3.1.5.2 Competitive Analysis
  • 3.2 Drug Therapy Products
    • 3.2.1 Oral Anticoagulation Agents
      • 3.2.1.1 Market Forecast
    • 3.2.2 Oral Antihypertensive Agents
      • 3.2.2.1 Market Forecast
    • 3.2.3 Oral Antiplatelet Agents
      • 3.2.3.1 Market Forecast
    • 3.2.4 Intravenous Thrombolytic Agents
      • 3.2.4.1 Market Forecast
  • 3.3 Interventional Stroke Management Systems
    • 3.3.1 Surgical and Endovascular Systems for Stroke Prophylaxis
      • 3.3.1.1 Carotid Endarterectomy
        • 3.3.1.1.1 Market Forecast
      • 3.3.1.2 Carotid Artery Stenting
        • 3.3.1.2.1 Market Forecast
        • 3.3.1.2.2 Competitive Analysis
      • 3.3.1.3 Cerebral Aneurysm/Arteriovenous Malformation Surgical Clipping Systems
        • 3.3.1.3.1 Market Forecast
        • 3.3.1.3.2 Competitive Analysis
      • 3.3.1.4 Cerebral Aneurysm/Arteriovenous Malformation Endovascular Embolization Systems
        • 3.3.1.4.1 Market Forecast
        • 3.3.1.4.2 Competitive Analysis
    • 3.3.2 Cerebrovascular Endovascular Systems for Stroke Treatment
      • 3.3.2.1 Cerebral Embolectomy/Mechanical Thrombectomy Products
        • 3.3.2.1.1 Market Forecast
        • 3.3.2.1.2 Competitive Analysis
        • 3.3.2.1.3 Emerging Cerebral Thrombectomy Systems
      • 3.3.2.2 Intracranial Stenting Systems
        • 3.3.2.2.1 Market Forecast
      • 3.3.2.3 Flow Diverter Technology
        • 3.3.2.3.1 Market Forecast
        • 3.3.2.3.2 Competitive Analysis
  • Exhibit 3-1: Stroke Management Products, Combined Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-2: Stroke Management Products, Combined Market Forecast, 2014-2019
  • Exhibit 3-3: Stroke Diagnostic Imaging, Combined Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-4: Stroke Diagnostic Imaging Products, Combined Market Forecast, 2014-2019
  • Exhibit 3-5: Computed Tomography, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-6: Computed Tomography, Market Forecast, 2014-2019
  • Exhibit 3-7: 2014, Computed Tomography Systems Market, Share by Supplier
  • Exhibit 3-8: Magnetic Resonance Imaging, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-9: Magnetic Resonance Imaging, Market Forecast, 2014-2019
  • Exhibit 3-10: 2014, Magnetic Resonance Imaging Systems Market, Share by Supplier
  • Exhibit 3-11: Diagnostic Ultrasound Imaging, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-12: Diagnostic Ultrasound Imaging Systems, Market Forecast, 2014-2019
  • Exhibit 3-13: 2014, Diagnostic Ultrasound Imaging Systems Market, Share by Supplier
  • Exhibit 3-14: Nuclear Medicine Imaging, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-15: Nuclear Medicine Imaging Systems, Market Forecast, 2014-2019
  • Exhibit 3-16: 2014, Nuclear Medicine Imaging Systems Market, Share
  • by Supplier
  • Exhibit 3-17: Cerebral Angiography, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-18: Cerebral Angiography Devices, Market Forecast, 2014-2019
  • Exhibit 3-19: 2014, Coronary Angiography Devices Market, Share by Supplier
  • Exhibit 3-20: Stroke-related Surgical and Endovascular Therapies, Combined Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-21: Stroke-related Surgical and Endovascular Therapies, Combined Market Forecast, 2014-2019
  • Exhibit 3-22: Carotid Endarterectomy, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-23: Carotid Endarterectomy, Market Forecast, 2014-2019
  • Exhibit 3-24: Distally Protected Carotid Artery Stenting, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-25: Distally Protected Carotid Artery Stenting, Market Forecast, 2014-2019
  • Exhibit 3-26: 2014, Distally Protected Carotid Artery Stenting Systems Market, Share by Supplier
  • Exhibit 3-27: Cerebral Aneurysm and Surgical AVM Repair, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-28: Cerebral Aneurysm and Surgical AVM Repair, Market Forecast, 2014-2019
  • Exhibit 3-29: 2014, Cerebral Aneurysm/AVM Clip Systems Market, Share by Supplier
  • Exhibit 3-30: Cerebral Aneurysm & AVM Endovascular Embolization, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-31: Cerebral Aneurysm & AVM Endovascular Embolization, Market Forecast, 2014-2019
  • Exhibit 3-32: 2014, Cerebral Aneurysm & AVM Endovascular Embolization Systems Market, Share by Supplier
  • Exhibit 3-33: Cerebral Thrombectomy, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-34: Cerebral Thrombectomy, Market Forecast, 2014-2019
  • Exhibit 3-35: 2014, Cerebral Thrombectomy Systems Market, Share by Supplier
  • Exhibit 3-36: Intracranial Stenting, Market Forecast, 2014-2019

APPENDIX: COMPANY LISTING

BIBLIOGRAPHY

Back to Top